Skip to main content

and
  1. Article

    Open Access

    Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

    Pazopanib is indicated in the first-line treatment of metastatic renal cell cancer (mRCC). The aim of this study was to review the efficacy, safety, and pharmacokinetics of pazopanib and see how these aspects ...

    María José Méndez-Vidal, Áurea Molina, Urbano Anido in BMC Pharmacology and Toxicology (2018)

  2. No Access

    Article

    Quality of life and supportive care for patients with metastatic renal cell carcinoma

    In recent years, a key issue in the management of patients with metastatic renal cell carcinoma (mRCC) has been the assessment of health-related quality of life (HRQoL), particularly following the introduction...

    Julio Lambea, Carmen Hinojo, Nuria Lainez, Martín Lázaro in Cancer and Metastasis Reviews (2012)

  3. No Access

    Article

    Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

    We carried out a genome-wide association study of breast cancer predisposition with replication and refinement studies involving 6,145 cases and 33,016 controls and identified two SNPs (rs4415084 and rs1094167...

    Simon N Stacey, Andrei Manolescu, Patrick Sulem, Steinunn Thorlacius in Nature Genetics (2008)